OVERVIEW

Getting Ahead of Migraine: Integrating Preventive Strategies Into Migraine Care is organized by CME Outfitters, LLC and will be held from Jun 13, 2018 - Jun 13, 2019.

Target Audience
Primary care physicians, internists, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with migraine.

Credit Information
CME Credit (Physicians):
CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Enduring: 0376-0000-18-009-H01-P

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Statement of Need
Migraine is a debilitating condition with profound effects on individuals' quality of life, accounting for five to nine million primary care visits each year. It is estimated that 38% of sufferers could benefit from preventative treatment, but few are currently using them nor are their healthcare providers discussing these options with them. Consequently, there is great interest in emerging data about calcitonin gene-related peptide (CGRP) agents as novel options for migraine prevention and the benefits they may provide to patients.

In this CME Outfitters recorded symposium, expert faculty discuss the evidence for new agents, share strategies to address migraine prophylaxis, and translate evidence to real-world clinical practice utilizing case-based learning, which will optimize changes in practice for healthcare providers.

Learning Objectives
At the end of this CE activity, participants should be able to:
• Apply knowledge of clinical features, symptoms, and key diagnostic criteria in the differential diagnosis of migraine.
• Assess safety and efficacy data supporting the role of agents that target CGRP in the prevention and management of migraine.
• Employ a patient-centered approach to the care of patients with migraine in order to improve outcomes, patient satisfaction, and treatment adherence.
The following learning objectives pertain only to those requesting CNE or CPE credit:
• Identify clinical features, symptoms, and key diagnostic criteria in the differential diagnosis of migraine.
• Explain safety and efficacy data supporting the role of agents that target CGRP in the prevention and management of migraine.
• Describe a patient-centered approach to the care of patients with migraine in order to improve outcomes, patient satisfaction, and treatment adherence.

Additional details will be posted as soon as they are available.